Thermostable BrCas12b Enzymes for One-Pot Nucleic Acid Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing CRISPR-based detection methods require separate amplification and detection steps due to the instability of Cas enzymes at elevated temperatures, increasing assay time and reducing sensitivity.

Innovation Solution

Development of genetically engineered BrCas12b enzymes with mutations that allow for one-pot, high-temperature nucleic acid detection by combining isothermal amplification components, CRISPR/Cas complexes, and labeled probes in a single reaction vessel, operating at 60-70°C.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If Cas enzymes are used at elevated temperatures for isothermal amplification, then detection speed and sensitivity are improved, but enzyme stability deteriorates

Engineering Contradiction:
Improvedetection speedVSAvoidenzyme stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent applies parameter changes by modifying the physical-chemical properties of the Cas enzyme through genetic engineering. Specifically, amino acid substitutions are introduced to alter the enzyme's thermal stability parameters, enabling it to maintain structural integrity and catalytic activity at elevated temperatures (60-70°C) required for isothermal amplification, thus resolving the contradiction between detection speed and enzyme stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite enzymatic system by combining the engineered Cas enzyme with isothermal amplification components (such as LAMP or RPA reagents) in a single reaction mixture. This composite approach allows the system to function effectively at elevated temperatures where both the amplification reaction and the engineered enzyme remain stable, achieving both rapid detection and enzyme stability

Inventive Principle:
Principle #40Composite materials

2Reliability

If separate amplification and detection steps are used, then reaction conditions are optimized, but assay time and complexity increase

Engineering Contradiction:
Improvereaction optimizationVSAvoidassay complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges the nucleic acid amplification step and the CRISPR-based detection step into a single isothermal reaction mixture. The engineered Cas enzyme maintains stability and activity at the elevated temperature required for isothermal amplification, allowing both amplification and detection to occur simultaneously in one pot, thereby reducing assay complexity and time while maintaining reaction optimization

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a multi-functional reaction system where a single reaction mixture performs both nucleic acid amplification and target detection functions. The engineered Cas enzyme serves dual purposes: it remains stable during isothermal amplification and subsequently performs specific target recognition and cleavage, eliminating the need for separate optimized reaction conditions and reducing overall assay complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid, sensitive, and cost-effective detection of nucleic acid targets by maintaining enzyme stability and efficiency at elevated temperatures, reducing assay time and complexity.

Implementation Method 1

a BrCas12b CRISPR-associated (Cas) enzyme; an sgRNA sequence having a CRISPR RNA (crRNA) sequence configured to bind to the target polynucleotide and a tracrRNA sequence configured to interact with the BrCas12b Cas enzyme to form a CRISPR/Cas complex upon binding of the crRNA sequence to the target polynucleotide

Methodology Applied
Scientific EffectCRISPR/Cas complex binding:

Implementation Method 2

wherein the probe is configured to be cleaved by the BrCas12b Cas enzyme when the crRNA sequence binds the target polynucleotide to generate a CRISPR-generated detectable signal or detectable molecule

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Implementation Method 3

a set of isothermal amplification components comprising isothermal amplification enzymes and primers configured to recognize and amplify the target polynucleotide

Methodology Applied
Scientific EffectIsothermal amplification:

Data Source

PatentUS20250283182A1Methods and systems for detecting a target using brcas12b and genetically engineered variants thereof
Publication Date: 2025.09.11 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US20250283182A1 patent drawing
  • US20250283182A1 patent drawing
  • US20250283182A1 patent drawing

AI summary

Novel genetically engineered thermostable Cas12b enzymes with greater thermal stability, higher melting point and/or increased trans-cleavage activity than wild type Cas 12b enzymes are provided. Methods, systems, and kits for one-pot detection of target polynucleotide are also provided that combine isothermal amplification with CRISPR-based detection with thermostable Cas enzymes in a single reaction vessel.